eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


5/2011
vol. 10
 
Share:
Share:
abstract:
Review paper

Alternative treatment of chemoresistant, recurrent or advanced ovarian cancer. Part II

Jacek R. Wilczyński
,
Beata Makuła

Przegląd Menopauzalny 2011; 5: 363–367
Online publish date: 2011/11/05
View full text Get citation
 
Lack of satisfactory efficacy of classical chemotherapy in ovarian tumours led to attempts of treatment based on use of small molecules able to modulate or inhibit intracellular pathways engaged in cell growth, proliferation and apoptosis. The paper presents clinical trials in ovarian cancer patients using such drugs as:

1) protein kinase inhibitors, 2) molecules interfering with DNA transcription and repair, 3) inhibitors of transcription factors NF-κB and HIF-1.
keywords:

ovarian cancer, PTKs, DNA, NF-κB, HIF-1

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.